323 results on '"Bu, Lin‐Lin"'
Search Results
2. Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
3. The applications of flexible electronics in dental, oral, and craniofacial medicine
4. Comparative analysis of GoPro and digital cameras in head and neck flap harvesting surgery video documentation: an innovative and efficient method for surgical education
5. Application of PRI-E–a combined learning method in oral and maxillofacial oncology education
6. Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives
7. Postoperative volume maintenance rate of microvascular free flap in oral and maxillofacial region: Systematic review and meta-analysis
8. Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment
9. Suicide among patients with oral cancer: A population-based study
10. Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety
11. Fluorine-doped carbon quantum dots with deep-red emission for hypochlorite determination and cancer cell imaging
12. Seizing the fate of lymph nodes in immunotherapy: To preserve or not?
13. NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma
14. Implantable versatile oxidized bacterial cellulose membrane for postoperative HNSCC treatment via photothermal-boosted immunotherapy
15. Nanotheranostics in cancer lymph node metastasis: The long road ahead
16. Recent advances in targeting myeloid-derived suppressor cells and their applications to radiotherapy
17. Myeloid-derived suppressor cells in head and neck squamous cell carcinoma
18. Enhancing Head and Neck Tumor Management with Artificial Intelligence: Integration and Perspectives
19. Analysis of intraoral microvascular anastomosis in maxillofacial defects reconstruction
20. Neoadjuvant immunotherapy: new horizon for lymph node preservation
21. Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma
22. Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy
23. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway
24. Comprehensive analysis of 65 patients with Castleman disease in a single center in China
25. Surgical margins in head and neck squamous cell carcinoma: A narrative review
26. Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors.
27. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.
28. LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.
29. Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care
30. Postoperative Volume Maintenance Rate of Microvascular Free Flap in Oral and Maxillofacial Region: Systematic Review and Meta-Analysis
31. A surge of hope: A case of lymph node hyperplasia after oral squamous cell carcinoma neoadjuvant immunotherapy
32. Editorial: Cuproptosis and tumor
33. Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
34. PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
35. Gelatinase-sensitive nanoparticles loaded with photosensitizer and STAT3 inhibitor for cancer photothermal therapy and immunotherapy
36. Advances in drug delivery for post-surgical cancer treatment
37. Single‐cell RNA sequencing reveals tumor heterogeneity within salivary gland pleomorphic adenoma: A preliminary study
38. Lymph node metastasis in oral squamous cell carcinoma: Where we are and where we are going
39. Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
40. Exploring Castleman disease in China: pre-IL-6 treatment era and advancements in knowledge
41. Data from Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
42. Supplementary Figure Legends from Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
43. Supplementary Figures from Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
44. Data from Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
45. Original Western Blot Data from Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
46. Supplementary Table 2 from Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
47. Supplementary Figures from Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
48. Supplementary Legends from Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
49. Supplementary Table 1 from Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
50. CD44 + cancer cell-induced metastasis: A feasible neck metastasis model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.